- Home
- GHY vs OFIX Comparison
GHY vs OFIX Comparison
Compare GHY & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GHY | OFIX |
|---|---|---|
| Founded | 2012 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 494.8M | 473.3M |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | GHY | OFIX |
|---|---|---|
| Price | $11.77 | $9.45 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $17.25 |
| AVG Volume (30 Days) | 104.6K | ★ 499.1K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | ★ 10.58% | N/A |
| EPS Growth | N/A | ★ 29.39 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $822,312,000.00 |
| Revenue This Year | N/A | $6.13 |
| Revenue Next Year | N/A | $6.22 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2.85 |
| 52 Week Low | $11.25 | $9.12 |
| 52 Week High | $13.72 | $16.99 |
Technical Indicators
Market Signals| Indicator | GHY | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 43.33 | 39.87 |
| Support Level | $11.25 | $9.13 |
| Resistance Level | $12.10 | $12.72 |
| Average True Range (ATR) | 0.11 | 0.43 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 11.59 | 22.60 |
Price Performance
Historical ComparisonAbout GHY PGIM Global High Yield Fund Inc.
PGIM Global High Yield Fund, Inc is a diversified, closed-end management investment company. The fund's investment objective is to provide a high level of current income. The fund seeks to provide a high level of current income by investing in higher-rated, below-investment-grade fixed income instruments of issuers located around the world, including emerging markets.
About OFIX Orthofix Medical Inc. (DE)
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.